Role of interleukin‐6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation
- 16 February 2005
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 204 (2) , 428-436
Abstract
The process of cardiac hypertrophy is considered to involve two components: that of cardiac myocyte (CM) enlargement and cardiac fibroblast (CF) proliferation. The interleukin‐6 (IL‐6) family cytokines have been implicated in a variety of cellular and molecular interactions between myocytes and non‐myocytes (NCMs), which in turn have important roles in the development of cardiac hypertrophy. In the study of these interactions, we previously detected very high levels of IL‐6 in supernatants of a “dedifferentiated model” of adult ventricular CMs cultured with CFs. In the present study, we have used this in vitro coculture system to examine how IL‐6 is involved in the interactions between CMs and CFs during CM hypertrophy and CF proliferation. IL‐6 and its signal transducer, 130‐kDa glycoprotein (gp130), were detected by immunostaining cultured CMs and CFs with anti‐IL‐6 or anti‐gp130 antibodies. Addition of anti‐IL‐6 or anti‐gp130 antagonist antibodies into CM/CF cocultures induced a significant decrease in expression of atrial natriuretic peptide (ANP) and β‐myosin heavy chain (β‐MHC) in CMs. The presence of IL‐6 antagonist also resulted in a decrease in the surface area of 12‐day‐old CMs cultured with CFs or in the presence of fibroblast conditioned medium (FCM), and decreased fibroblast proliferation in CM/CF cocultures, particularly in the presence of a gp130 antagonist. The results also show that angiotensin II (AngII) is mainly secreted by CFs and induces IL‐6 secretion in CMs cultured with CFs or with FCM. In addition, the effects of IL‐6 on cardiomyocyte hypertrophy and fibroblast proliferation were inhibited by addition of the AT‐1 receptor antagonist, losartan. These results suggest that IL‐6 contributes significantly to CM hypertrophy by an autocrine pathway and to fibroblast proliferation by a paracrine pathway and that these effects could be mediated by AngII.Keywords
This publication has 39 references indexed in Scilit:
- Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferationJournal of Cellular Physiology, 2004
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- Cardiotrophin-1 Stimulation of Cardiac Fibroblast GrowthCirculation Research, 2002
- Involvement of Nuclear Factor-κB and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte HypertrophyCirculation, 2002
- Augmented Expression of Cardiotrophin-1 and its Receptor Component, gp130, in both Left and Right Ventricles after Myocardial Infarction in the RatJournal of Molecular and Cellular Cardiology, 2000
- Autocrine/Paracrine Secretion of IL-6 Family Cytokines Causes Angiotensin II-Induced Delayed STAT3 ActivationBiochemical and Biophysical Research Communications, 2000
- Endothelin-1 and Cardiotrophin-1 Induce Brain Natriuretic Peptide Expression by Distinct Transcriptional MechanismsJournal of Cardiovascular Pharmacology, 1998
- Angiotensin II Induced Expression of Transcription Factors Precedes Increase in Transforming Growth Factor-β1 mRNA in Neonatal Cardiac FibroblastsBiochemical and Biophysical Research Communications, 1994
- Adult rat cardiomyocytes in cultureTrends in Cardiovascular Medicine, 1994
- Interleukin-6 Stimulates Proliferation of Cultured Vascular Smooth Muscle Cells Independently of Interleukin-1βJournal of Cardiovascular Pharmacology, 1991